Go back

Wiley introduces broader licensing for open access journals

Publishing company Wiley-Blackwell has revised its licensing arrangements to allow the commercial use of articles published in open access journals, including EMBO Molecular Medicine.

Publications in Wiley’s Open Access Program will adopt the Creative Commons Attribution (CC-BY) licence, meaning articles can be used, distributed, reproduced and adapted for any medium, including commercial use.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.